PathWhiz ID | Pathway | Meta Data |
---|---|---|
PW109038View Pathway |
signaling
Intracellular Signalling Through PGD2 receptor and Prostaglandin D2Bos taurus
PGD is the major prostanoid released from human mast cells upon immunological challenge. Prostaglandin D2 (PGD2) can trigger asthmatic responses by acting as a cell-derived mediator in mice. The PGD receptor activates G(s) proteins which lead to the activation of adenylyl cyclase which produces the secondary messenger cAMP. cAMP activates PKA (protein kinase A) which phosphorylates downstream effectors that lead to a specific cellular response.
|
Creator: Ana Marcu Created On: August 31, 2018 at 11:44 Last Updated: August 31, 2018 at 11:44 |
PW109027View Pathway |
signaling
Intracellular Signalling Through PGD2 receptor and Prostaglandin D2Mus musculus
PGD is the major prostanoid released from human mast cells upon immunological challenge. Prostaglandin D2 (PGD2) can trigger asthmatic responses by acting as a cell-derived mediator in mice. The PGD receptor activates G(s) proteins which lead to the activation of adenylyl cyclase which produces the secondary messenger cAMP. cAMP activates PKA (protein kinase A) which phosphorylates downstream effectors that lead to a specific cellular response.
|
Creator: Ana Marcu Created On: August 31, 2018 at 11:43 Last Updated: August 31, 2018 at 11:43 |
PW000451View Pathway |
signaling
Intracellular Signalling Through PGD2 receptor and Prostaglandin D2Homo sapiens
PGD is the major prostanoid released from human mast cells upon immunological challenge. Prostaglandin D2 (PGD2) can trigger asthmatic responses by acting as a cell-derived mediator in mice. The PGD receptor activates G(s) proteins which lead to the activation of adenylyl cyclase which produces the secondary messenger cAMP. cAMP activates PKA (protein kinase A) which phosphorylates downstream effectors that lead to a specific cellular response.
|
Creator: WishartLab Created On: August 22, 2013 at 10:46 Last Updated: August 22, 2013 at 10:46 |
PW109048View Pathway |
signaling
Intracellular Signalling Through PGD2 receptor and Prostaglandin D2Rattus norvegicus
PGD is the major prostanoid released from human mast cells upon immunological challenge. Prostaglandin D2 (PGD2) can trigger asthmatic responses by acting as a cell-derived mediator in mice. The PGD receptor activates G(s) proteins which lead to the activation of adenylyl cyclase which produces the secondary messenger cAMP. cAMP activates PKA (protein kinase A) which phosphorylates downstream effectors that lead to a specific cellular response.
|
Creator: Ana Marcu Created On: August 31, 2018 at 11:46 Last Updated: August 31, 2018 at 11:46 |
PW109049View Pathway |
signaling
Intracellular Signalling Through Prostacyclin Receptor and ProstacyclinRattus norvegicus
Cyclooxygenase is the major producer of prostacyclin. Prostacyclin binding to its receptor increases vasodilation and decreases platelet aggregation. The receptor is a G-protein coupled receptor, upon its binding it activates G proteins causing the activation of adenylyl cyclase and production of cAMP messenger molecules. cAMP activates PKA (protein kinase A) which phosphorylates downstream effectors that lead to a specific cellular response.In vasodilation, the PKA activity causes phosphorylation of MLCK, decreasing its activity, resulting in dephosphorylation of MLC of myosin. This leads to smooth muscle relaxation resulting in vasodilation.
|
Creator: Ana Marcu Created On: August 31, 2018 at 11:46 Last Updated: August 31, 2018 at 11:46 |
PW109039View Pathway |
signaling
Intracellular Signalling Through Prostacyclin Receptor and ProstacyclinBos taurus
Cyclooxygenase is the major producer of prostacyclin. Prostacyclin binding to its receptor increases vasodilation and decreases platelet aggregation. The receptor is a G-protein coupled receptor, upon its binding it activates G proteins causing the activation of adenylyl cyclase and production of cAMP messenger molecules. cAMP activates PKA (protein kinase A) which phosphorylates downstream effectors that lead to a specific cellular response.In vasodilation, the PKA activity causes phosphorylation of MLCK, decreasing its activity, resulting in dephosphorylation of MLC of myosin. This leads to smooth muscle relaxation resulting in vasodilation.
|
Creator: Ana Marcu Created On: August 31, 2018 at 11:44 Last Updated: August 31, 2018 at 11:44 |
PW109029View Pathway |
signaling
Intracellular Signalling Through Prostacyclin Receptor and ProstacyclinMus musculus
Cyclooxygenase is the major producer of prostacyclin. Prostacyclin binding to its receptor increases vasodilation and decreases platelet aggregation. The receptor is a G-protein coupled receptor, upon its binding it activates G proteins causing the activation of adenylyl cyclase and production of cAMP messenger molecules. cAMP activates PKA (protein kinase A) which phosphorylates downstream effectors that lead to a specific cellular response.In vasodilation, the PKA activity causes phosphorylation of MLCK, decreasing its activity, resulting in dephosphorylation of MLC of myosin. This leads to smooth muscle relaxation resulting in vasodilation.
|
Creator: Ana Marcu Created On: August 31, 2018 at 11:43 Last Updated: August 31, 2018 at 11:43 |
PW000452View Pathway |
signaling
Intracellular Signalling Through Prostacyclin Receptor and ProstacyclinHomo sapiens
Cyclooxygenase is the major producer of prostacyclin. Prostacyclin binding to its receptor increases vasodilation and decreases platelet aggregation. The receptor is a G-protein coupled receptor, upon its binding it activates G proteins causing the activation of adenylyl cyclase and production of cAMP messenger molecules. cAMP activates PKA (protein kinase A) which phosphorylates downstream effectors that lead to a specific cellular response.In vasodilation, the PKA activity causes phosphorylation of MLCK, decreasing its activity, resulting in dephosphorylation of MLC of myosin. This leads to smooth muscle relaxation resulting in vasodilation.
|
Creator: WishartLab Created On: August 22, 2013 at 10:46 Last Updated: August 22, 2013 at 10:46 |
PW132377View Pathway |
Iobenguane Drug MetabolismHomo sapiens
Iobenguane is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Iobenguane passes through the liver and is then excreted from the body mainly through the kidney.
|
Creator: Ray Kruger Created On: September 21, 2023 at 21:20 Last Updated: September 21, 2023 at 21:20 |
PW145745View Pathway |
drug action
Iobenguane Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 16:32 Last Updated: October 07, 2023 at 16:32 |